Status:
RECRUITING
Fluorescence-Guided Optimization of Sarcoma Margins
Lead Sponsor:
University of Aarhus
Conditions:
Soft Tissue Sarcoma of the Trunk and Extremities
Sarcoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a Danish national multicenter prospective cohort study to evaluate if fluorescence-guided surgery (FGS) using indocyanine green (ICG) can reduce the rate of positive margins following sarcoma ...
Detailed Description
This is a Danish national multicenter prospective cohort study to evaluate if fluorescence-guided surgery (FGS) using indocyanine green (ICG) can reduce the rate of positive margins following sarcoma ...
Eligibility Criteria
Inclusion
- Biopsy verified intermediate-to-high grade sarcoma of theextremity or trunk wall
- Age\>18 years old
- Tumor operable
- Curative intent at time of surgery
- Consent of patient
Exclusion
- History of allergic reaction to iodine-containing pharmaceuticals
- End-stage renal disease or eGFR \<15
- Patient decision
- Lack of capacity
- Inoperability
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07134192
Start Date
September 1 2025
End Date
March 1 2028
Last Update
December 4 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus N, Denmark, 8200
2
Rigshospitalet
Copenhagen, Denmark, 2100